Macrophage-Dendritic Cell-T-Cell Tetrads Orchestrate Antitumor Immunity and Response to Checkpoint Blockade
Year: 2025
Type: article
Language: en
Topic: Immune cells in cancer
Authors and affiliations:
raw_author_name: Mehdi Chaib
raw_affiliation_strings: Department of Immunology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA
raw_author_name: Muhammad Aminu
raw_affiliation_strings: Department of Imaging Physics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA
raw_author_name: Shelley Herbrich
raw_affiliation_strings: Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA
raw_author_name: Mahshid Arabi
raw_affiliation_strings: Department of Immunology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA
raw_author_name: Yue Xuan
raw_affiliation_strings: Department of Immunology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA
raw_author_name: Akshay Basi
raw_affiliation_strings: Department of Hematopoietic Biology & Malignancy, Division of Cancer Medicine
raw_author_name: Anna Casasent
raw_affiliation_strings: Department of Hematopoietic Biology & Malignancy, Division of Cancer Medicine
raw_author_name: Marc D. Macaluso
raw_affiliation_strings: Immunotherapy Platform, James P. Allison Institute, The University of Texas MD Anderson Cancer Center, Houston, TX, USA
raw_author_name: Kenneth H. Hu
raw_affiliation_strings: Department of Immunology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA
James P. Allison Institute, The University of Texas MD Anderson Cancer Center, Houston, TX, USA
raw_author_name: Matthew Gubin
raw_affiliation_strings: Department of Immunology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA
raw_author_name: Xi Chen
raw_affiliation_strings: Department of Experimental Therapeutics, Division of Cancer Medicine
James P. Allison Institute, The University of Texas MD Anderson Cancer Center, Houston, TX, USA
raw_author_name: James J. Mancuso
raw_affiliation_strings: Department of Immunology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA
James P. Allison Institute, The University of Texas MD Anderson Cancer Center, Houston, TX, USA
raw_author_name: Sreyashi Basu
raw_affiliation_strings: Immunotherapy Platform, James P. Allison Institute, The University of Texas MD Anderson Cancer Center, Houston, TX, USA
raw_author_name: Sonali Jindal
raw_affiliation_strings: Immunotherapy Platform, James P. Allison Institute, The University of Texas MD Anderson Cancer Center, Houston, TX, USA
raw_author_name: Jared Burks
raw_affiliation_strings: Department of Hematopoietic Biology & Malignancy, Division of Cancer Medicine
raw_author_name: Stephanie Watowich
raw_affiliation_strings: Department of Immunology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA
raw_author_name: Jia Wu
raw_affiliation_strings: Department of Imaging Physics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA
raw_author_name: James P. Allison
raw_affiliation_strings: Department of Immunology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA
Immunotherapy Platform, James P. Allison Institute, The University of Texas MD Anderson Cancer Center, Houston, TX, USA
James P. Allison Institute, The University of Texas MD Anderson Cancer Center, Houston, TX, USA
Parker Institute for Cancer Immunotherapy, The University of Texas MD Anderson Cancer Center, Houston, TX, USA
raw_author_name: Padmanee Sharma
raw_affiliation_strings: Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA
Department of Imaging Physics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA
Department of Immunology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA
Immunotherapy Platform, James P. Allison Institute, The University of Texas MD Anderson Cancer Center, Houston, TX, USA
James P. Allison Institute, The University of Texas MD Anderson Cancer Center, Houston, TX, USA